147P Population-adjusted Indirect Comparisons of Repotrectinib and Entrectinib in ROS1+ Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ESMO Open(2024)
Key words
Non-Small Cell Lung Cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined